Akari Therapeutics, Statistics
Total Valuation
AKTX has a market cap or net worth of $39.56 million. The enterprise value is $40.22 million.
| Market Cap | 39.56M |
| Enterprise Value | 40.22M |
Important Dates
The last earnings date was Wednesday, April 16, 2025, before market open.
| Earnings Date | Apr 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AKTX has 28.88 million shares outstanding. The number of shares has increased by 144.03% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 28.88M |
| Shares Change (YoY) | +144.03% |
| Shares Change (QoQ) | +59.17% |
| Owned by Insiders (%) | 50.04% |
| Owned by Institutions (%) | 1.10% |
| Float | 14.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15, with a Debt / Equity ratio of 0.15.
| Current Ratio | 0.15 |
| Quick Ratio | 0.13 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -68.23 |
Financial Efficiency
Return on equity (ROE) is -179.92% and return on invested capital (ROIC) is -82.38%.
| Return on Equity (ROE) | -179.92% |
| Return on Assets (ROA) | -37.89% |
| Return on Invested Capital (ROIC) | -82.38% |
| Return on Capital Employed (ROCE) | -54.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.20M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.14% in the last 52 weeks. The beta is 0.58, so AKTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +18.14% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 2.06 |
| Relative Strength Index (RSI) | 57.65 |
| Average Volume (20 Days) | 29,677 |
Short Selling Information
| Short Interest | 76,994 |
| Short Previous Month | 75,637 |
| Short % of Shares Out | 0.44% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.65M |
| Pretax Income | n/a |
| Net Income | -19.79M |
| EBITDA | -16.63M |
| EBIT | -16.65M |
| Earnings Per Share (EPS) | -$1.66 |
Balance Sheet
The company has $2.60 million in cash and $3.26 million in debt, giving a net cash position of -$661,000 or -$0.02 per share.
| Cash & Cash Equivalents | 2.60M |
| Total Debt | 3.26M |
| Net Cash | -661,000 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | 22.23M |
| Book Value Per Share | 0.84 |
| Working Capital | -16.96M |
Cash Flow
| Operating Cash Flow | -12.55M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.55M |
| FCF Per Share | -$0.43 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AKTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -144.03% |
| Shareholder Yield | -144.03% |
| Earnings Yield | -50.03% |
| FCF Yield | -31.73% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 17, 2023. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Aug 17, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |